Medpace Holdings (MEDP) Stock Forecast & Price Target
MEDP Analyst Ratings
Moderate Buy
3Buy6Hold0Sell
Based on 9 analysts giving stock ratings to Medpace Holdings in the past 3 months
MEDP Stock 12 Month Forecast
Average Price Target
MXN 12,534.55▲(78.50% Upside)Based on 9 Wall Street analysts offering 12 month price targets for Medpace Holdings in the last 3 months. The average price target is MXN 12,534.55 with a high forecast of MXN 13,652.52 and a low forecast of MXN 10,473.16. The average price target represents a 78.50% change from the last price of MXN 7,022.03.
Past 12 Months12 Month ForecastDec2025Sep2026
HighMXN 13.65K
AverageMXN 12.53K
LowMXN 10.47K
Highest Price TargetHighestMXN 13,652.52Average Price TargetMXN 12,534.55Lowest Price TargetLowestMXN 10,473.16
Detailed List of Analyst Forecasts
Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| Sean Dodge | BMO Capital | MXN 11,221.25→MXN 12,530.39 | hold | 78.44%Upside | Assigned | 10/26/26 | ||
| Luke Sergott | Barclays | MXN 11,688.80→MXN 12,623.90 | hold | 79.78%Upside | Reiterated | 10/23/26 | ||
| Charles Rhyee | TD Cowen | MXN 9,201.42→MXN 12,586.50 | hold | 79.24%Upside | Assigned | 10/23/26 | ||
| Eric Coldwell | Robert W. Baird | MXN 11,931.92→MXN 13,072.75 | buy | 86.17%Upside | Reiterated | 10/23/26 | ||
| Ann Hynes | Mizuho Securities | MXN 13,091.45→MXN 13,652.52 | buy | 94.42%Upside | Reiterated | 10/23/26 | ||
| Kevin Caliendo | UBS | MXN 12,586.50→MXN 13,091.45 | hold | 86.43%Upside | Assigned | 10/23/26 | ||
| Jailendra Singh | Truist Financial | MXN 11,389.56→MXN 11,838.41 | hold | 68.59%Upside | Reiterated | 10/23/26 | ||
| Ryan Halsted | RBC Capital | MXN 12,941.84 | buy | 84.30%Upside | Reiterated | 10/22/26 | ||
| David Windley | Jefferies | MXN 9,631.57→MXN 10,473.16 | hold | 49.15%Upside | Reiterated | 09/14/26 | ||
| Jared Haase | William Blair | ― | hold | ― | Reiterated | 07/23/26 | ||
| Justin Bowers | Deutsche Bank | MXN 8,977.00→MXN 10,005.61 | hold | 42.49%Upside | Reiterated | 07/23/26 | ||
| Michael Cherny | Leerink Partners | MXN 9,631.57→MXN 11,595.29 | hold | 65.13%Upside | Reiterated | 07/23/26 |
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| Sean Dodge | 10/26/26 | MXN 11,221.25→MXN 12,530.39 | hold | 78.44%Upside | Assigned | BMO Capital | ||
| Luke Sergott | 10/23/26 | MXN 11,688.80→MXN 12,623.90 | hold | 79.78%Upside | Reiterated | Barclays | ||
| Charles Rhyee | 10/23/26 | MXN 9,201.42→MXN 12,586.50 | hold | 79.24%Upside | Assigned | TD Cowen | ||
| Eric Coldwell | 10/23/26 | MXN 11,931.92→MXN 13,072.75 | buy | 86.17%Upside | Reiterated | Robert W. Baird | ||
| Ann Hynes | 10/23/26 | MXN 13,091.45→MXN 13,652.52 | buy | 94.42%Upside | Reiterated | Mizuho Securities | ||
| Kevin Caliendo | 10/23/26 | MXN 12,586.50→MXN 13,091.45 | hold | 86.43%Upside | Assigned | UBS | ||
| Jailendra Singh | 10/23/26 | MXN 11,389.56→MXN 11,838.41 | hold | 68.59%Upside | Reiterated | Truist Financial | ||
| Ryan Halsted | 10/22/26 | MXN 12,941.84 | buy | 84.30%Upside | Reiterated | RBC Capital | ||
| David Windley | 09/14/26 | MXN 9,631.57→MXN 10,473.16 | hold | 49.15%Upside | Reiterated | Jefferies | ||
| Jared Haase | 07/23/26 | ― | hold | ― | Reiterated | William Blair | ||
| Justin Bowers | 07/23/26 | MXN 8,977.00→MXN 10,005.61 | hold | 42.49%Upside | Reiterated | Deutsche Bank | ||
| Michael Cherny | 07/23/26 | MXN 9,631.57→MXN 11,595.29 | hold | 65.13%Upside | Reiterated | Leerink Partners |
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Best Analysts Covering Medpace Holdings
3 Months
Success Rate6/12 ratings generated profit
50%
Average Return
+7.03%
Copying Ann Hynes's trades and holding each position for 3 Months would result in 50.00% of your transactions generating a profit, with an average return of +7.03% per trade.
1 Year
Success Rate11/12 ratings generated profit
92%
Average Return
+31.06%
Copying Ann Hynes's trades and holding each position for 1 Year would result in 91.67% of your transactions generating a profit, with an average return of +31.06% per trade.
2 Years
Success Rate12/12 ratings generated profit
100%
Average Return
+51.88%
Copying Ann Hynes's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +51.88% per trade.
MEDP Analyst Recommendation Trends
| Rating | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 5 | 6 | 6 | 5 | 5 |
| Hold | 6 | 12 | 12 | 14 | 9 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 11 | 18 | 18 | 19 | 14 |
In the current month, MEDP has received 5 Buy Ratings, 9 Hold Ratings, and 0 Sell Ratings. MEDP average Analyst price target in the past 3 months is 12,534.55.
MEDP Financial Forecast
HighMXN 92.58
ConsensusMXN 90.41
LowMXN 89.13
MEDP Earnings Forecast
Next quarter’s earnings estimate for MEDP is MXN 90.41 with a range of MXN 89.13 to MXN 92.58. The previous quarter’s EPS was MXN 90.52. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
HighMXN 13.6B
ConsensusMXN 13.4B
LowMXN 13.3B
MEDP Sales Forecast
Next quarter’s sales forecast for MEDP is MXN 13.44B with a range of MXN 13.28B to MXN 13.56B. The previous quarter’s sales results were MXN 13.39B. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.
MEDP Stock Forecast FAQ
What is MX:MEDP’s average 12-month price target, according to analysts?
Based on analyst ratings, Medpace Holdings’s 12-month average price target is Mex$12,534.55.
What is MX:MEDP’s upside potential, based on the analysts’ average price target?
Medpace Holdings has 78.50% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Medpace Holdings a Buy, Sell or Hold?
Medpace Holdings has a consensus rating of Moderate Buy, which is based on 3 buy ratings, 6 hold ratings and 0 sell ratings.
What is Medpace Holdings’s share price target?
The average share price target for Medpace Holdings is Mex$12,534.55. This is based on 9 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is Mex$13,652.52, and the lowest forecast is Mex$10,473.16. The average share price target represents a 78.50% increase from the current price of Mex$7,022.03.
What do analysts say about Medpace Holdings?
Medpace Holdings’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 9 Wall Street analysts.
How can I buy shares of Medpace Holdings?
To buy shares of MX:MEDP, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
